Search

Your search keyword '"Radia, D"' showing total 187 results
Start Over Author "Radia, D"
187 results on '"Radia, D"'

1. PCR81 Diagnosis and Treatment Patterns in European Patients with Systemic Mastocytosis

Author

Triggiani, M., primary, Mesa, R., additional, Hobart, J., additional, Green, T., additional, Powell, D., additional, Gressier-Sayag, C., additional, Baisley, W., additional, Lahue, B., additional, Rueff, F., additional, Schinhofen, W., additional, Hegmann, N., additional, Livideanu, C., additional, Beaux, A., additional, Marcis, P., additional, Alvarez-Twose, I., additional, Ribada, E., additional, Radia, D., additional, and Finnerty, C., additional

Published
2023
Full Text
View/download PDF

2. PCR136 The Burden of Systemic Mastocytosis in Select European Countries: Evidence from the Prism Patient Survey

Author

Mesa, R., primary, Triggiani, M., additional, Hobart, J., additional, Green, T., additional, Powell, D., additional, Gressier-Sayag, C., additional, Baisley, W., additional, Lahue, B., additional, Rueff, F., additional, Schinhofen, W., additional, Hegmann, N., additional, Livideanu, C., additional, Beaux, A., additional, Marcis, P., additional, Alvarez-Twose, I., additional, Ribada, E., additional, Radia, D., additional, and Finnerty, C., additional

Published
2023
Full Text
View/download PDF

3. Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal

Author

Valent, P., Sotlar, K., Sperr, W.R., Escribano, L., Yavuz, S., Reiter, A., George, T.I., Kluin-Nelemans, H.C., Hermine, O., Butterfield, J.H., Hägglund, H., Ustun, C., Hornick, J.L., Triggiani, M., Radia, D., Akin, C., Hartmann, K., Gotlib, J., Schwartz, L.B., Verstovsek, S., Orfao, A., Metcalfe, D.D., Arock, M., and Horny, H.-P.

Published
2014
Full Text
View/download PDF

5. Anemia management: development of a rapid-access anemia and intravenous iron service

Author

Radia D, Momoh I, Dillon R, Francis Y, Cameron L, Fagg TL, Overl, H, Robinson S, and Harrison CN

Subjects
Public aspects of medicine, RA1-1270
Abstract

Deepti Radia,1 Ibrahim Momoh,2 Richard Dillon,1 Yvonne Francis,1 Laura Cameron,1 Toni-Lee Fagg,1 Hannah Overland,1 Susan Robinson,1 Claire N Harrison11Haematology Department, Guy's and St Thomas' NHS Foundation Trust, London, UK; 2Bupa Home Healthcare, Harlow, UKAbstract: This article describes the initiation and evolution of the Rapid-Access Anemia Clinic (RAAC) at Guy's and St Thomas' Hospitals, London, UK. This clinic was set up to provide diagnosis and treatment, and to coordinate investigative procedures, where necessary, into the underlying causes of anemia. Initially piloted with anemic preoperative orthopedic patients, the clinic now treats a wide range of conditions, deriving from both internal and external referrals. Treatment includes dietary advice, supplementation with iron, vitamin B12 and folate, and blood transfusion. Most patients at the RAAC need iron replacement, the majority of which require intravenous (IV) iron. Therefore the first-line IV iron-administration protocol is carefully considered to ensure viability of the service and patient satisfaction. Four IV irons available in the UK are discussed, with explanation of the benefits and drawbacks of each product and the reasoning behind the IV iron choice at different stages of the RAAC's development. Costs to the service, affected by IV iron price and administration regimen, are considered, as well as the product's contraindications. Finally, the authors reflect on the success of the RAAC and how it has improved patients' quality-of-treatment experience, in addition to benefiting the hospital and National Health Service in achieving specific health-care mandates and directives. Drawing from the authors' experiences, recommendations are given to assist others in setting up and providing a successful rapid-access anemia service or similar facility.Keywords: hemoglobin, iron deficiency, ferric carboxymaltose, iron sucrose, iron dextran, iron isomaltoside

Published
2013

7. P990: T CELL RESPONSE AND OMICRON VARIANT NEUTRALISATION FOLLOWING VACCINATION AGAINST SARS-COV-2 IN PATIENTS WITH CHRONIC MYELOID DISORDERS

Author

Harrington, P., primary, Saunders, J., additional, Saha, C., additional, Sheikh, A., additional, Dillon, R., additional, Raj, K., additional, Cadman-Davies, L., additional, Lechmere, T., additional, Khan, H., additional, Woodley, C., additional, Asirvatham, S., additional, Curto-Garcia, N., additional, O’Sullivan, J., additional, Kordasti, S., additional, Radia, D., additional, McLornan, D., additional, Malim, M., additional, Doores, K., additional, Harrison, C., additional, and de Lavallade, H., additional

Published
2022
Full Text
View/download PDF

10. P1015: DURATION OF TREATMENT AND REDUCTION IN SERUM TRYPTASE LEVELS IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS TREATED WITH AVAPRITINIB VERSUS BEST AVAILABLE THERAPY

Author

Reiter, A., primary, Gotlib, J., additional, Álvarez-Twose, I., additional, Radia, D. H., additional, Luebke, J., additional, Bobbili, P. J., additional, Wang, A., additional, Norregaard, C., additional, Dimitrijević, S., additional, Sullivan, E., additional, Louie-Gao, M., additional, Schwaab, J., additional, Galinsky, I. A., additional, Perkins, C., additional, Sperr, W. R., additional, Sriskandarajah, P., additional, Chin, A., additional, Sendhil, S. R., additional, Duh, M. S., additional, Valent, P., additional, and DeAngelo, D. J., additional

Published
2022
Full Text
View/download PDF

11. P1013: OVERALL SURVIVAL IN PATIENTS WITH SYSTEMIC MASTOCYTOSIS WITH ASSOCIATED HEMATOLOGIC NEOPLASM TREATED WITH AVAPRITINIB VERSUS BEST AVAILABLE THERAPY

Author

Reiter, A., primary, Gotlib, J., additional, Álvarez-Twose, I., additional, Radia, D. H., additional, Luebke, J., additional, Bobbili, P. J., additional, Wang, A., additional, Norregaard, C., additional, Dimitrijević, S., additional, Sullivan, E., additional, Louie-Gao, M., additional, Schwaab, J., additional, Galinsky, I. A., additional, Perkins, C., additional, Sperr, W. R., additional, Sriskandarajah, P., additional, Chin, A., additional, Sendhil, S. R., additional, Duh, M. S., additional, Valent, P., additional, and DeAngelo, D. J., additional

Published
2022
Full Text
View/download PDF

13. P1014: OVERALL SURVIVAL IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS RECEIVING AVAPRITINIB VERSUS MIDOSTAURIN OR CLADRIBINE

Author

Reiter, A., primary, Gotlib, J., additional, Álvarez-Twose, I., additional, Radia, D. H., additional, Luebke, J., additional, Bobbili, P. J., additional, Wang, A., additional, Norregaard, C., additional, Dimitrijević, S., additional, Sullivan, E., additional, Louie-Gao, M., additional, Schwaab, J., additional, Galinsky, I. A., additional, Perkins, C., additional, Sperr, W. R., additional, Sriskandarajah, P., additional, Chin, A., additional, Sendhil, S. R., additional, Duh, M. S., additional, Valent, P., additional, and DeAngelo, D. J., additional

Published
2022
Full Text
View/download PDF

14. Efficacy and safety of avapritinib in previously treated patients with advanced systemic mastocytosis

Author

Reiter, A., Schwaab, J., Deangelo, D. J., Gotlib, J., Deininger, M. W., Pettit, K. M., Alvarez-Twose, I., Vannucchi, A. M., Panse, J., Platzbecker, U., Hermine, O., Dybedal, I., Lin, H. -M., Rylova, S. N., Ehlert, K., Dimitrijevic, S., Radia, D. H., Drummond, M., Hexner, E., Bose, P., Robinson, W., Hunter, A., Tashi, T., Heaney, M., Mesa, R., Ustun, C., Oh, S., Griffiths, E., Sperr, W., Livideanu, C., Triggiani, M., and Zanotti, R.

Subjects
Adult, Proto-Oncogene Proteins c-kit, Mastocytosis, Systemic, Humans, Pyrazoles, Pyrroles, Hematology
Abstract

Advanced systemic mastocytosis (AdvSM) is a rare myeloid neoplasm, driven by the KIT D816V mutation in >90% of patients. Avapritinib, a potent, highly selective D816V-mutant KIT inhibitor, is approved for treatment of adults with AdvSM by the US Food and Drug Administration, regardless of prior therapy, and the European Medicines Agency for patients with prior systemic therapy, based on EXPLORER (#NCT02561988; clinicaltrials.gov) and PATHFINDER (#NCT03580655; clinicaltrials.gov) clinical studies. We present latest pooled efficacy and safety analyses from patients who received ≥1 systemic therapy prior to avapritinib in EXPLORER/PATHFINDER. Overall response rate in response-evaluable patients (n = 31) was 71% (95% confidence interval: 52% to 86%; 22/31), including 19% (6/31) with complete remission (CR)/CR with partial recovery of peripheral blood counts (CRh). Median time to response was 2.3 months, median time to CR/CRh was 7.4 months, and median duration of response (DOR) was not reached. Reductions ≥50% in bone marrow mast cell infiltration (89%), KIT D816V variant allele fraction (66%), serum tryptase (89%), and reductions ≥35% in spleen size (70%) occurred in most patients. Median OS was not reached (median follow-up 17.7 months). Avapritinib was effective in all AdvSM subtypes, regardless of number/type of prior therapies or poor prognostic somatic mutations. Treatment-related adverse events (TRAEs) were observed in 94% of patients, most commonly grade 1/2; 57% had TRAEs of at least grade 3; 81% remained on treatment at 6 months. Avapritinib in adults with AdvSM who received prior systemic therapy was generally well tolerated, with high response rates regardless of prior systemic therapy.

Published
2022

21. Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis

Author

Valent, P., Escribano, L., Broesby-Olsen, S., Hartmann, K., Grattan, C., Brockow, K., Niedoszytko, M., Nedoszytko, B., Oude Elberink, J. N. G., Kristensen, T., Butterfield, J. H., Triggiani, M., Alvarez-Twose, I., Reiter, A., Sperr, W. R., Sotlar, K., Yavuz, S., Kluin-Nelemans, H. C., Hermine, O., Radia, D., van Doormaal, J. J., Gotlib, J., Orfao, A., Siebenhaar, F., Schwartz, L. B., Castells, M., Maurer, M., Horny, H.-P., Akin, C., Metcalfe, D. D., and Arock, M.

Published
2014
Full Text
View/download PDF

23. Analysis of wheat protein composition by high pressure liquid chromatography (SE-HPLC AND RP-HPLC) in some regions of Algeria.

Author

Nesrine, H., Radia, D., Abdelkader, D., and Marie-Francoise, S.

Subjects
*WHEAT proteins, *HIGH performance liquid chromatography, *DURUM wheat, *MOLECULAR weights, *GLUTELINS
Abstract

An assay of ten semi-durum wheat genotypes at different sites in the Algerian regions was the subject of this study in order to identify durum wheat cultivars with good or poor quality by means of HPLC analysis. To this end, the protein quality parameters have mainly focused on the analysis of the protein composition of wheat by high pressure liquid chromatography (SE-HPLC and RPHPLC) this analysis improves the separation performance by placing the mobile phase under pressure (more precise, faster). HPLC was used to amplify the sequences of omega, alpha, beta and gamma gliadins and low molecular weight glutenins (SG-FPM or LMW-GS from genomic DNA of durum wheat genotypes. The yield and quality of durum wheat produced in Algeria, selected according to their area of development, are still difficult to control because they are highly subject to genotype x environment interactions. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

28. Role and evolution of viral tropism in patients with advanced HIV disease receiving intensified initial regimen in the ANRS 130 APOLLO trial

Author

Charpentier, Charlotte, Joly, Véronique, Larrouy, Lucile, Fagard, Catherine, Visseaux, Benoit, de Verdière, Nathalie Colin, Raffi, François, Yeni, Patrick, Descamps, Diane, Aumaître, H., Medus, M., Neuville, S., Saada, M., Abgrall, S., Bentata, M., Bouchaud, O., Cailhol, J., Cordel, H., Dhote, R., Gros, H., Honoré-Berlureau, P., Huynh, T., Krivitzky, A., Mansouri, R., Poupard, M., Prendki, V., Radia, D., Rouges, F., Touam, F., Warde, B., de Castro, N., Colin de Verdière, N., Delgado, J., Ferret, S., Gallien, S., Kandel, T., Lafaurie, M., Lagrange, M., Lascoux-Combe, C., Le, D., Molina, J. M., Pavie, J., Pintado, C., Ponscarme, D., Rachline, A., Rozenbaum, W., Sereni, D., Taulera, O., Estavoyer, J. M., Faucher, J. F., Foltzer, A., Hoen, B., Hustache-Mathieu, L., Dupon, M., Dutronc, H., Neau, D., Ragnaud, J. M., Raymond, I., Boucly, S., Lortholary, O., Viard, J. P., Bechara, C., Delfraissy, J. F., Ghosn, J., Goujard, C., Kamouh, W., Môle, M., Quertainmont, Y., Bergmann, J. F., Boulanger, E., Castillo, H., Parrinello, M., Rami, A., Sellier, P., Lepeu, G., Pichancourt, G., Bernard, L., Berthé, H., Clarissou, J., Gory, M., Melchior, J. C., Perronne, C., Stegman, S., de Truchis, P., Derradji, O., Malet, M., Teicher, E., Vittecoq, D., Chakvetadze, C., Fontaine, C., Lukiana, T., Pialloux, G., Slama, L., Bonnet, D., Boucherit, S., El Alami Talbi, N., Fournier, I., Gervais, A., Joly, V., Iordache, L., Laurichesse, J. J., Leport, C., Pahlavan, G., Phung, B. C., Yeni, P., Bennamar, N., Brunet, A., Guillevin, L., Salmon-Ceron, D., Tahi, T., Chesnel, C., Dominguez, S., Jouve, P., Lelièvre, J. D., Levy, Y., Melica, G., Sobel, A., Ben Abdallah, S., Bonmarchand, M., Bricaire, F., Herson, S., Iguertsira, M., Katlama, C., Kouadio, H., Schneider, L., Simon, A., Valantin, M. A., Abel, S., Beaujolais, V., Cabié, A., Liauthaud, B., Pierre François, S., Abgueguen, P., Chennebault, J. M., Loison, J., Pichard, E., Rabier, V., Delaune, J., Louis, I., Morlat, P., Pertusa, M. C., Brunel-Delmas, F., Chiarello, P., Jeanblanc, F., Jourdain, J. J., Livrozet, J. M., Makhloufi, D., Touraine, J. L., Augustin-Normand, C., Bailly, F., Benmakhlouf, N., Brochier, C., Cotte, L., Gueripel, V., Koffi, K., Lack, P., Lebouché, B., Maynard, M., Miailhes, P., Radenne, S., Schlienger, I., Thoirain, V., Trepo, C., Drogoul, M. P., Fabre, G., Faucher, O., Frixon-Marin, V., Gastaut, J. A., Peyrouse, E., Poizot-Martin, I., Jacquet, J. M., Le Facher, G., Merle de Boever, C., Reynes, J., Tramoni, C., Allavena, C., Billaud, E., Biron, C., Bonnet, B., Bouchez, S., Boutoille, D., Brunet-François, C., Hüe, H., Mounoury, O., Raffi, F., Reliquet, V., Aubry, O., Esnault, J. L., Leautez-Nainville, S., Perré, P., Suaud, I., Bréaud, S., Ceppi, C., Dellamonica, P., De Salvador, F., Durant, J., Ferrando, S., Fuzibet, J. G., Leplatois, A., Mondain, V., Perbost, I., Pugliese, P., Rahelinirina, V., Rosenthal, E., Sanderson, F., Vassalo, M., Arvieux, C., Chapplain, J. M., Michelet, C., Ratajczak, M., Revest, M., Souala, F., Tattevin, P., Chéneau, C., Fischer, P., Lang, J. M., Partisani, M., Rey, D., Bastides, F., Besnier, J. M., Le Bret, P., Choutet, P., Dailloux, J. F., Guadagnin, P., Nau, P., Rivalain, J., Soufflet, A., Aïssi, E., Melliez, H., Pavel, S., Mouton, Y., Yazdanpanah, Y., Boyer, L., Burty, C., Letranchant, L., May, T., Wassoumbou, S., Blum, L., Danne, O., Arthus, M. A., Dion, P., Certain, A., Tabuteau, S., Beuscart, A., Agher, N., Frosch, A., Couffin-Cadiergues, S., and Diallo, A.

Published
2013
Full Text
View/download PDF

35. PRO143 PSYCHOMETRIC EVALUATION OF THE ADVANCED SYSTEMIC MASTOCYTOSIS SYMPTOM ASSESSMENT FORM (ADVSM-SAF) IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS

Author

Taylor, F., primary, Shields, A., additional, Li, S., additional, Yip, C., additional, Padilla, B., additional, Green, T., additional, Radia, D., additional, Deininger, M., additional, Gotlib, J.R., additional, Bose, P., additional, Drummond, M.W., additional, Hexner, E., additional, Robinson, W., additional, Quiery, A., additional, Winton, E.F., additional, DeAngelo, D.J., additional, and Mar, B., additional

Published
2019
Full Text
View/download PDF

36. S830 AVAPRITINIB, A POTENT AND SELECTIVE INHIBITOR OF KIT D816V, INDUCES COMPLETE AND DURABLE RESPONSES IN PATIENTS (PTS) WITH ADVANCED SYSTEMIC MASTOCYTOSIS (ADVSM)

Author

Radia, D., primary, Deininger, M.W., additional, Gotlib, J., additional, Bose, P., additional, Drummond, M.W., additional, Hexner, E.O., additional, Robinson, W.A., additional, Quiery, A.T., additional, Winton, E., additional, George, T.I., additional, Horny, H.-P., additional, Oren, R., additional, Shi, H., additional, Schmidt-Kittler, O., additional, Mar, B., additional, and DeAngelo, D.J., additional

Published
2019
Full Text
View/download PDF

37. Skeletal muscle mass reference curves for children and adolescents

Author

McCarthy, HD, Samani-Radia, D, Jebb, SA, and Prentice, AM

Abstract

BACKGROUND: Skeletal muscle is key to motor development and represents a major metabolic end organ that aids glycaemic regulation. OBJECTIVES: To create gender-specific reference curves for fat-free mass (FFM) and appendicular (limb) skeletal muscle mass (SMMa) in children and adolescents. To examine the muscle-to-fat ratio in relation to body mass index (BMI) for age and gender. METHODS: Body composition was measured by segmental bioelectrical impedance (BIA, Tanita BC418) in 1985 Caucasian children aged 5-18.8 years. Skeletal muscle mass data from the four limbs were used to derive smoothed centile curves and the muscle-to-fat ratio. RESULTS: The centile curves illustrate the developmental patterns of %FFM and SMMa. While the %FFM curves differ markedly between boys and girls, the SMMa (kg), %SMMa and %SMMa/FFM show some similarities in shape and variance, together with some gender-specific characteristics. Existing BMI curves do not reveal these gender differences. Muscle-to-fat ratio showed a very wide range with means differing between boys and girls and across fifths of BMI z-score. CONCLUSIONS: BIA assessment of %FFM and SMMa represents a significant advance in nutritional assessment since these body composition components are associated with metabolic health. Muscle-to-fat ratio has the potential to provide a better index of future metabolic health.

Published
2016
Full Text
View/download PDF

38. The role of sexuality symptoms in myeloproliferative neoplasm symptom burden and quality of life: An analysis by the MPN QOL International Study Group

Author

Geyer, H. L., Andreasson, B., Kosiorek, H. E., Dueck, A. C., Scherber, R. M., Martin, K. A., Butler, K. A., Harrison, C. N., Radia, D. H., Cervantes, F., Kiladjian, J. J., Reiter, A., Birgegard, G., Passamonti, Francesco, Senyak, Z., Vannucchi, A. M., Paoli, C., Xiao, Z., Samuelsson, J., and Mesa, R. A.

Subjects
hematological neoplasms, quality of life, symptoms, myeloproliferative neoplasms, sexuality
Published
2016

40. SYMPTOMS, RISK CLASSIFICATION, AND SPLEEN SIZE IN JAK2 INHIBITOR-NAIVE MYELOFIBROSIS : IMPLICATIONS FOR JAK2 INHIBITOR TREATMENT

Author

Scherber, R., Dueck, A., Geyer, H., Kosiorek, H., Kiladjian, J. J., Slot, S., Zweegman, S., Boekhorst, P., Schouten, H., Sackmann, F., Fuentes, A., Hernandez-Maraver, D., Pahl, H., Stegelmann, F., Doehner, K., Bonatz, K., Reiter, A., Boyer, F., Etienne, G., Ianotto, J. C., Ranta, D., Roy, L., Cahn, J. Y., Harrison, C., Radia, D., Muxi, P., Maldonado, N., Besses, C., Cervantes, F., Johansson, P., Barosi, G., Vannucchi, A., Passamonti, F., Andreasson, B., Samuelsson, J., Birgegård, Gunnar, Sun, X., Xu, J., Zhang, P., Xu, Z., Barbui, T., Senyak, Z., Grieshammer, M., Rambaldi, A., Ferrari, M., Lehmann, T., Mesa, R., Scherber, R., Dueck, A., Geyer, H., Kosiorek, H., Kiladjian, J. J., Slot, S., Zweegman, S., Boekhorst, P., Schouten, H., Sackmann, F., Fuentes, A., Hernandez-Maraver, D., Pahl, H., Stegelmann, F., Doehner, K., Bonatz, K., Reiter, A., Boyer, F., Etienne, G., Ianotto, J. C., Ranta, D., Roy, L., Cahn, J. Y., Harrison, C., Radia, D., Muxi, P., Maldonado, N., Besses, C., Cervantes, F., Johansson, P., Barosi, G., Vannucchi, A., Passamonti, F., Andreasson, B., Samuelsson, J., Birgegård, Gunnar, Sun, X., Xu, J., Zhang, P., Xu, Z., Barbui, T., Senyak, Z., Grieshammer, M., Rambaldi, A., Ferrari, M., Lehmann, T., and Mesa, R.

Published
2016

41. Development Of An Mf Patient Reported Outcome (Pro) Tool For Fda Qualification : Comprehensive Literature Search And Physician Cognitive Debriefing Results

Author

Geyer, H., Kosiorek, H., Dueck, A., Slot, S., Zweegman, S., Kiladjian, J. J., Boekhorst, P., Schouten, H., Sackmann, F., Fuentes, A., Hernandez-Maraver, D., Pahl, H., Stegelmann, F., Doehner, K., Bonatz, K., Reiter, A., Boyer, F., Etienne, G., Ianotto, J. C., Ranta, D., Roy, L., Cahn, J. Y., Harrison, C., Radia, D., Muxi, P., Maldonado, N., Besses, C., Cervantes, F., Johansson, P., Barosi, G., Passamonti, F., Andreasson, B., Samuelsson, J., Birgegård, Gunnar, Sun, X., Xu, J., Zhang, P., Xu, Z., Barbui, T., Senyak, Z., Grieshammer, M., Rambaldi, A., Ferrari, M., Lehmann, T., Scherber, R., Mesa, R., Geyer, H., Kosiorek, H., Dueck, A., Slot, S., Zweegman, S., Kiladjian, J. J., Boekhorst, P., Schouten, H., Sackmann, F., Fuentes, A., Hernandez-Maraver, D., Pahl, H., Stegelmann, F., Doehner, K., Bonatz, K., Reiter, A., Boyer, F., Etienne, G., Ianotto, J. C., Ranta, D., Roy, L., Cahn, J. Y., Harrison, C., Radia, D., Muxi, P., Maldonado, N., Besses, C., Cervantes, F., Johansson, P., Barosi, G., Passamonti, F., Andreasson, B., Samuelsson, J., Birgegård, Gunnar, Sun, X., Xu, J., Zhang, P., Xu, Z., Barbui, T., Senyak, Z., Grieshammer, M., Rambaldi, A., Ferrari, M., Lehmann, T., Scherber, R., and Mesa, R.

Published
2016

42. Impact Of Splenomegaly On Mpn Symptoms And Association With Clinical Features : An Analysis By The Mpn Quality Of Life International Study Group

Author

Geyer, H., Scherber, R., Kosiorek, H., Dueck, A., Kiladjian, J. J., Slot, S., Zweegman, S., Boekhorst, P., Schouten, H., Sackmann, F., Fuentes, A., Hernandez-Maraver, D., Pahl, H., Stegelmann, F., Doehner, K., Bonatz, K., Reiter, A., Boyer, F., Etienne, G., Ianotto, J. C., Ranta, D., Roy, L., Cahn, J. Y., Harrison, C., Radia, D., Muxi, P., Maldonado, N., Besses, C., Cervantes, F., Johansson, P., Barosi, G., Vannucchi, A., Passamonti, F., Andreasson, B., Samuelsson, J., Birgegård, Gunnar, Sun, X., Xu, J., Zhang, P., Xu, Z., Barbui, T., Senyak, Z., Grieshammer, M., Rambaldi, A., Ferrari, M., Lehmann, T., Mesa, R., Geyer, H., Scherber, R., Kosiorek, H., Dueck, A., Kiladjian, J. J., Slot, S., Zweegman, S., Boekhorst, P., Schouten, H., Sackmann, F., Fuentes, A., Hernandez-Maraver, D., Pahl, H., Stegelmann, F., Doehner, K., Bonatz, K., Reiter, A., Boyer, F., Etienne, G., Ianotto, J. C., Ranta, D., Roy, L., Cahn, J. Y., Harrison, C., Radia, D., Muxi, P., Maldonado, N., Besses, C., Cervantes, F., Johansson, P., Barosi, G., Vannucchi, A., Passamonti, F., Andreasson, B., Samuelsson, J., Birgegård, Gunnar, Sun, X., Xu, J., Zhang, P., Xu, Z., Barbui, T., Senyak, Z., Grieshammer, M., Rambaldi, A., Ferrari, M., Lehmann, T., and Mesa, R.

Published
2016

45. PRIMARY MYELOFIBROSIS, POST-ET AND POST-PV MYELOFIBROSIS HAVE DISTINCT CLINICAL PROFILES AND SYMPTOMATIC BURDENS : AN ANALYSIS BY THE MPN QUALITY OF LIFE INTERNATIONAL STUDY GROUP (MPN-QOL ISG)

Author

Geyer, H., Kosiorek, H., Scherber, R., Dueck, A., Jean-Jacques, K., Xiao, Z., Zweegman, S., Sackman, F., Hernandez-Maraver, D., Dohner, K., Harrison, C., Radia, D., Muxi, P., Besses, C., Cervantes, F., Johansson, P., Andreasson, B., Rambaldi, A., Barbui, T., Vannucchi, A., Passamonti, F., Samuelsson, J., Birgegård, Gunnar, Bonatz, K., Reiter, A., Boyer, F., Etienne, G., Ianotto, J. -C, Ranta, D., Roy, L., Cahn, J. -Y, Maldonado, N., Barosi, G., Ferrari, M., Cannon, K., te Boekhorst, P. A. W., Klauke, K., Schouten, H., Pahl, H., Griesshammer, M., Stegelmann, F., Lehmann, T., Xu, Z., Zhang, Y., Sun, X., Xu, J., Zhang, P., Mesa, R., Geyer, H., Kosiorek, H., Scherber, R., Dueck, A., Jean-Jacques, K., Xiao, Z., Zweegman, S., Sackman, F., Hernandez-Maraver, D., Dohner, K., Harrison, C., Radia, D., Muxi, P., Besses, C., Cervantes, F., Johansson, P., Andreasson, B., Rambaldi, A., Barbui, T., Vannucchi, A., Passamonti, F., Samuelsson, J., Birgegård, Gunnar, Bonatz, K., Reiter, A., Boyer, F., Etienne, G., Ianotto, J. -C, Ranta, D., Roy, L., Cahn, J. -Y, Maldonado, N., Barosi, G., Ferrari, M., Cannon, K., te Boekhorst, P. A. W., Klauke, K., Schouten, H., Pahl, H., Griesshammer, M., Stegelmann, F., Lehmann, T., Xu, Z., Zhang, Y., Sun, X., Xu, J., Zhang, P., and Mesa, R.

Published
2015

46. Target interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growth

Author

Peter, B, primary, Winter, G E, additional, Blatt, K, additional, Bennett, K L, additional, Stefanzl, G, additional, Rix, U, additional, Eisenwort, G, additional, Hadzijusufovic, E, additional, Gridling, M, additional, Dutreix, C, additional, Hoermann, G, additional, Schwaab, J, additional, Radia, D, additional, Roesel, J, additional, Manley, P W, additional, Reiter, A, additional, Superti-Furga, G, additional, and Valent, P, additional

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results